AAAAAA

   
Results: 1-14 |
Results: 14

Authors: MORRISON C SHAH S FLINN IW
Citation: C. Morrison et al., LEPTOMENINGEAL INVOLVEMENT IN CHRONIC LYMPHOCYTIC-LEUKEMIA, Cancer practice, 6(4), 1998, pp. 223-228

Authors: BYRD JC FLINN IW GREVER MR
Citation: Jc. Byrd et al., INTRODUCTION - CHRONIC LYMPHOCYTIC-LEUKEMIA, Seminars in oncology, 25(1), 1998, pp. 4-5

Authors: FLINN IW VOGELSANG G
Citation: Iw. Flinn et G. Vogelsang, BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA, Seminars in oncology, 25(1), 1998, pp. 60-64

Authors: BYRD JC SHINN C WASELENKO JK FUCHS EJ LEHMAN TA NGUYEN PL FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FLAVOPIRIDOL INDUCES APOPTOSIS IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS VIA ACTIVATION OF CASPASE-3 WITHOUT EVIDENCE OF BCL-2 MODULATION OR DEPENDENCE ON FUNCTIONAL P53, Blood, 92(10), 1998, pp. 3804-3816

Authors: BYRD JC SHINN CA BEDI A WASELENKO JK FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., UCN-O1 - A PROMISING NEW AGENT FOR B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) THAT INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS, Blood, 90(10), 1997, pp. 4125-4125

Authors: WASELENKO JK BYRD JC SHINN CA FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jk. Waselenko et al., CARBOXYAMIDO-TRIAZOLE (CAI), A SIGNAL-TRANSDUCTION INHIBITOR, DEMONSTRATES MARGINAL ACTIVITY AGAINST HUMAN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA IN-VITRO, Blood, 90(10), 1997, pp. 4147-4147

Authors: WASELENKO JK GREVER MR SHINN CA FLINN IW DIEHL LF BYRD JC
Citation: Jk. Waselenko et al., GEMCITABINE DEMONSTRATES SIGNIFICANT IN-VITRO ACTIVITY IN HEAVILY PRETREATED B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 4148-4148

Authors: FLINN IW MORRISON C MILLER C AMBINDER RF JONES RJ
Citation: Iw. Flinn et al., GOOD PROGNOSIS FOR PATIENTS WHO RECEIVE BMT AFTER HISTORY OF LYMPHOMATOUS MENINGITIS, Blood, 90(10), 1997, pp. 1670-1670

Authors: BYRD JC SHINN CA BEDI A WASELENKO JK FUCHS E FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FLAVOPIRIDOL HAS MARKED IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND INDUCES APOPTOSIS INDEPENDENT OF P53 STATUS, Blood, 90(10), 1997, pp. 2366-2366

Authors: BYRD JC WASELENKO JK SHINN CA BEDI A FLINN IW DIEHL LF SAUSVILLE E GREVER MR
Citation: Jc. Byrd et al., FR901228, A NOVEL ANTITUMOR BICYCLIC DEPSIPEPTIDE, HAS SIGNIFICANT IN-VITRO ACTIVITY AGAINST HUMAN B-CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL), Blood, 90(10), 1997, pp. 2367-2367

Authors: BYRD JC WASELENKO JK SHINN CA FLINN IW DIEHL LF GREVER M
Citation: Jc. Byrd et al., INTERLEUKIN-4 INDUCES RESISTANCE TO F-ARA-A AND UCN-01, BUT NOT FLAVOPIRIDOL IN A BCL-2 INDEPENDENT MANNER, Blood, 90(10), 1997, pp. 2368-2368

Authors: FLINN IW KOPECKY KJ FOUCAR MK HEAD D BENNETT JM HUTCHISON RE CORBETT WEN CASSILETH PA HABERMANN T GOLOMB H RAI K EISENHAUER E APPELBAUM FR CHESON BD GREVER M
Citation: Iw. Flinn et al., LONG-TERM RESULTS IN HAIRY-CELL LEUKEMIA (HCL) TREATED WITH PENTOSTATIN, Blood, 90(10), 1997, pp. 2575-2575

Authors: FLINN IW GREVER MR
Citation: Iw. Flinn et Mr. Grever, CHRONIC LYMPHOCYTIC-LEUKEMIA, Cancer treatment reviews, 22(1), 1996, pp. 1-13

Authors: FLINN IW BYRD JC SEIFTER E MARCELLUS D LEE N DIEHL LF AMBINDER RF GREVER MR VOGELSANG G
Citation: Iw. Flinn et al., FLUDARABINE AND CYCLOPHOSPHAMIDE AS FIRST THERAPY FOR INDOLENT LYMPHOPROLIFERATIVE DISORDERS - RESPONSE RATES AND TOXICITY, Blood, 88(10), 1996, pp. 2345-2345
Risultati: 1-14 |